Company / Total Assets
Bristol Myers Squibb Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$90.0B
FY2025
5-year range
$90.0B / $109.3B
FY2021-FY2025
Trend
-2.8%
vs FY2024
Sector context
#7 of 214
Health Care
What the data says
Among 214 Health Care companies, Bristol Myers Squibb is in the top 3% for total assets. Total Assets has declined for 5 consecutive years, from $118.5B in FY2020 to $90.0B in FY2025.
Based on SEC 10-K filings.
$90.0B in FY2025 with a 5-year CAGR of -5.3%. Top quartile in the Health Care sector.
Declined from $95.2B to $90.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -2.4%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 214This company $90.0B Sector average $7.5B
▼
+1105.4% above sector average
Key checks
Key Insights
- Bristol Myers Squibb's total assets has declined for 5 consecutive years.
- 5-year CAGR of -5.3%, indicating a declining trend.
- In FY2025, total assets decreased 2.8% year-over-year.
- Ranks #7 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $90.0B | -2.8% |
| FY2024 | $92.6B | -2.7% |
| FY2023 | $95.2B | -1.7% |
| FY2022 | $96.8B | -11.4% |
| FY2021 | $109.3B | -7.7% |
| FY2020 | $118.5B | +240.1% |
| FY2019 | $34.8B | +5.3% |
| FY2018 | $33.1B | +0.4% |
| FY2017 | $32.9B | +3.3% |
| FY2016 | $31.9B | -5.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026